New combined treatments, surgery and high-dose-rate interventional radiotherapy (brachytherapy), in advanced ocular surface and eyelid cancers
Postoperative HDR-IRT has been effective in advanced eyelid cancers control. More challenging appears instead an effective treatment of advanced OSSNs, particularly conjunctival melanomas. Multicenter studies are needed to get a larger patient sample and to evaluate different radiotherapy dosages by different histologic and T types of tumors.
Authors
- Bruno Fionda (ORCID: https://orcid.org/0000-0003-3368-1810)
- Francesco Pastore (ORCID: https://orcid.org/0000-0003-0505-7295)
- Giovanni Cuffaro (ORCID: https://orcid.org/0000-0001-6068-9979)
- Federico Giannuzzi (ORCID: https://orcid.org/0000-0001-5962-852X)
- Gustavo Savino (ORCID: https://orcid.org/0000-0002-9993-5986)
- Maria Grazia Sammarco
- Luca Tagliaferri (ORCID: https://orcid.org/0000-0003-2308-0982)
- Flavia Quaranta Leoni
- Monica Maria Pagliara
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Agostino Gemelli University Polyclinic (IT)
- Advanced Radiation Therapy (United States) (US)
Publication Details
- Journal
- Translational Oncology
- Published
- 2024-11-05
- DOI
- https://doi.org/10.1016/j.tranon.2024.102160
- Citations
- 3
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.62